News:
Deutsch (DE-CH-AT)
Recent publications
  • Nicholson LJ, Smith PR, Hiller L, Szlosarek PW, Kimberley C, Sehouli J, Koensgen D, Mustea A, Schmid P, Crook T. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer. Int J Cancer. 2009 Apr 27.
  • Faggad A, Darb-Esfahani S, Wirtz R, Sinn B, Sehouli J, Könsgen D, Lage H, Noske A, Weichert W, Buckendahl AC, Budczies J, Müller BM, Elwali NE, Dietel M, Denkert C. Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis. Histopathology. 2009 May;54(6):657-66.
  • Sehouli J, Senyuva F, Fotopoulou C, Neumann U, Denkert C, Werner L, Gülten OO. Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer. J Surg Oncol. 2009 Jun 1;99(7):424-7.
  • Denkert C, Budczies J, Darb-Esfahani S, Györffy B, Sehouli J, Könsgen D, Zeillinger R, Weichert W, Noske A, Buckendahl AC, Müller BM, Dietel M, Lage H. A prognostic gene expression index in ovarian cancer - validation across different independent data sets. J Pathol. 2009 Jun;218(2):273-80.
  • Auner V, Kriegshäuser G, Tong D, Horvat R, Reinthaller A, Mustea A, Zeillinger R. KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay. BMC Cancer. 2009 Apr 9;9:111.
  • Faggad A, Darb-Esfahani S, Wirtz R, Sinn B, Sehouli J, Könsgen D, Lage H, Weichert W, Noske A, Budczies J, Müller BM, Buckendahl AC, Röske A, Eldin Elwali N, Dietel M, Denkert C. Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis. Mod Pathol. 2009 Apr;22(4):579-88. Epub 2009 Mar 6.
  • Keller S, König AK, Marmé F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 2009 Jun 8;278(1):73-81. Epub 2009 Feb 1.
  • J.Sehouli and W.Lichtenegger, Department of Gynecology and Obstetrics, Charité, Medical University Berlin, Germany. 1st Capital Congress of the Gynecologic Oncology of the North-Eastern German Society of Gynecological Oncology, Poster Abstracts, ANTICANCER RESEARCH 29: xxx-xxx(2009)
  • Keller S, König AK, Marmé F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P., Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes, Cancer Lett. 2009 Jan 31
 

ISO 9001 Certified

In the process of the certification for European Competence Center for Ovarian Cancer, in 2007 and 2008 TOC was also certified by the TÜV Süd (ISO 9001)
RocketTheme Joomla Templates